Mortality Trends in Men and Women with Diabetes, 1971-2000

National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341-3727, USA.
Annals of internal medicine (Impact Factor: 17.81). 09/2007; 147(3):149-55.
Source: PubMed


Whether mortality rates among diabetic adults or excess mortality associated with diabetes in the United States has declined in recent decades is not known.
To examine whether all-cause and cardiovascular disease mortality rates have declined among the U.S. population with and without self-reported diabetes.
Comparison of 3 consecutive, nationally representative cohorts.
Population-based health surveys (National Health and Nutrition Examination Surveys I, II, and III) with mortality follow-up assessment.
Survey participants age 35 to 74 years with and without diabetes.
Diabetes was determined by self-report for each survey (1971-1975, 1976-1980, and 1988-1994), and mortality rates were determined through 1986, 1992, and 2000 for the 3 surveys, respectively.
Among diabetic men, the all-cause mortality rate decreased by 18.2 annual deaths per 1000 persons (from 42.6 to 24.4 annual deaths per 1000 persons; P = 0.03) between 1971 to 1986 and 1988 to 2000, accompanying decreases in the nondiabetic population. Trends for cardiovascular disease mortality paralleled those of all-cause mortality, with 26.4 annual deaths per 1000 persons in 1971 to 1986 and 12.8 annual deaths per 1000 persons in 1988 to 2000 (P = 0.06). Among women with diabetes, however, neither all-cause nor cardiovascular disease mortality declined between 1971 to 1986 and 1988 to 2000, and the all-cause mortality rate difference between diabetic and nondiabetic women more than doubled (from a difference of 8.3 to 18.2 annual deaths per 1000 persons). The difference in all-cause mortality rates by sex among people with diabetes in 1971 to 1986 were essentially eliminated in 1988 to 2000.
Diabetes was assessed by self-report, and statistical power to examine the factors explaining mortality trends was limited.
Progress in reducing mortality rates among persons with diabetes has been limited to men. Diabetes continues to greatly increase the risk for death, particularly among women.

  • Source
    • "Cross-sectional studies have reported that the control of cardiovascular risk factors (CVRF) is poorer among diabetic women relative to diabetic men of the same age [30] [31] [32]. Moreover, the follow-up of the population in the National Health and Nutrition Examination Surveys (NHANES) has shown that, for the past years, there has been an overall decline in mortality rates due to CVD, but not in the subgroup of diabetic women [33]. On the other hand, studies derived from the analysis of large databases have proven to be useful for evaluating cardiometabolic control, associated risk factors, long-term complications, and other clinically relevant aspects of T2DM [34] [35] [36] [37]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this cross-sectional study was to assess differences in the control and treatment of modifiable cardiovascular risk factors (CVRF: HbA1c, blood pressure [BP], LDL-cholesterol, body mass index, and smoking habit) according to gender and the presence of cardiovascular disease (CVD) in patients with type 2 diabetesmellitus (T2DM) in Catalonia, Spain. The study included available data from electronic medical records for a total of 286,791 patients. After controlling for sex, age, diabetes duration, and treatment received, both men and women with prior CVD had worse cardiometabolic control than patients without previous CVD; women with prior CVD had worse overall control of CVRFs than men except for smoking; and women without prior CVD were only better than men at controlling smoking and BP, with no significant differences in glycemic control. Finally, although the proportion of women treated with lipid-lowering medications was similar to (with prior CVD) or even higher (without CVD) than men, LDL-cholesterol levels were remarkably uncontrolled in both women with and women without CVD. The results stress the need to implement measures to better prevent and treat CVRF in the subgroup of diabetic women, specifically with more intensive statin treatment in those with CVD.
    Full-text · Article · Sep 2014 · International Journal of Endocrinology
  • Source
    • "The prevalence and incidence of diabetes mellitus are increasing worldwide, especially in the elder patients regardless of the status of HIV infection [10], [28]–[30]. Presence of diabetes mellitus is associated with a higher mortality rate among HIV-uninfected patients [31]–[34] because of increased risk of cardiovascular diseases, nephropathy, retinopathy, and neuropathy [35], [36]. Whether the incidence of diabetes mellitus is higher in HIV-infected patients than HIV-uninfected individuals remains controversial. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Background With the widespread use of combination antiretroviral therapy (cART), life expectancy of HIV-infected patients has significantly prolonged. An increasing number of HIV-infected patients are aging and concurrent use of medications are not uncommon for management of metabolic complications and cardiovascular diseases related to aging and prolonged exposure to cART. Methods We reviewed medical records of all HIV-infected patients aged 40 years or older who had been followed at a university hospital for HIV care in Taiwan between January and December 2013. A standardized case record form was used to collect information on demographics and clinical characteristics, comorbidity, cART, and concurrent medications. Results During the study period, 610 patients aged 40 to 49 years (mean, 44.1) and 310 aged 50 years or older (mean, 58.8) sought HIV care at this hospital. Compared with patients aged 40 to 49 years, those aged 50 years or older were significantly more likely to be female (15.9% vs 3.8%); to have received cART (97.7% vs 94.8%) and a lower plasma HIV RNA load (1.6 vs 1.7 log10 copies/ml); and to have diabetes mellitus (18.4% vs 4.6%), hypertension (31.0% vs 10.8%), hyperlipidemia (29.4% vs 11.6%), coronary artery disease (6.8% vs 0.5%), and an estimated glomerular filtration rate <60 ml/min/1.73 m2 (11.5% vs 2.7%); and were significantly less likely to have syphilis. Other than HIV infection, patients aged 50 years or older were more likely to have been receiving two or more concurrent medications than those aged 40 to 49 years (22.9% vs 6.4%). Conclusions Our findings show a significant proportion of the HIV-infected patients aged 50 years or older have multiple comorbidities that may increase the risk for cardiovascular and renal complications. Issues of poly-pharmacy among the HIV-infected patients who are aging should be addressed to ensure adherence and minimize drug-drug interactions.
    Full-text · Article · Aug 2014 · PLoS ONE
  • Source
    • "The main long-term complications from diabetes are vascular diseases, which are in turn the main causes of morbidity and mortality in diabetic patients (1). Diabetic vascular complications affect several important organs, including the retina, kidney, and arteries (2,3). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Decreased collateral vessel formation in the diabetic peripheral limbs is characterised by abnormalities of the angiogenic response to ischemia. Hyperglycemia is known to activate protein kinase C (PKC) affecting the expression and activity of growth factors such as VEGF and PDGF. The present study investigates the role of PKCδ in diabetes-induced poor collateral vessel formation and inhibition of angiogenic factors expression and actions. Ischemic adductors muscles of diabetic Prkcd(+/+) mice exhibited reduced blood reperfusion, vascular density and number of small vessels as compared to non-diabetic Prkcd(+/+) mice. By contrast, diabetic Prkcd(-/-) mice showed significant increased blood flow, capillary density and number of capillaries. Although expression of various PKC isoforms were unchanged, activation of PKCδ was increased in diabetic Prkcd(+/+) mice. VEGF and PDGF mRNA and protein expression were decreased in muscles of diabetic Prkcd(+/+) mice and normalized in diabetic Prkcd(-/-) mice. Furthermore, phosphorylation of VEGFR2 and PDGFR-β were blunted in diabetic Prkcd(+/+) mice but elevated in diabetic Prkcd(-/-) mice. The inhibition of VEGFR2 and PDGFR-β activity was associated with increased SHP-1 expression. In conclusion, our data have uncovered the mechanisms by which PKCδ activation induced poor collateral vessel formation offering potential novel targets to regulate angiogenesis therapeutically in diabetic patients.
    Full-text · Article · Apr 2013 · Diabetes
Show more